Silver Book Fact

According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.

Houston K. Innovative Drugs Cost Patients Less in the Long Run. Chicago Sun Times. 30-Jul-2004

Reference

Title
Innovative Drugs Cost Patients Less in the Long Run
Publication
Chicago Sun Times
Publication Date
30-Jul-2004
Authors
Houston K

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Beta-Blocker Treatment After A Heart Attack: Trends, 1996-2006  
  • In the 1980s, approximately 400,000 major infarctions were occurring each year in the U.S. and 40% of patients were dying within the first year. 1-year mortality is now 4-8%.  
  • The development of antioxidants that reduce oxidative damage is underway. One antioxidant that has been found, uric acid, has an even greater protective effect when combined with tPA.  
  • In 2001, 86,000 more premature deaths from cardiovascular disease (50,000 men and 36,000 women) would have occurred among Americans age 40 and older without antihypertensive drug therapy.  
  • From 1994 to 2004, death rates from cardiovascular disease declined 24.7%.